HGF and cancer: Biweekly intratumoral injection with HGF at a dosage of 30 μg/kg for 4 consecutive weeks enhanced the penetration of MDA-MB-436 cancer cells into the adjacent normal tissues, which was not seen with PBS injection (Figure 6A).